Introduction
In April 2003, at the BioAnalysis Working Group (BAWG) of the Comité Consultatif de la Quantité de Matière (CCQM) meeting in Paris, NIST and LGC jointly proposed a comparison to quantitate plasmid DNA using quantitative amplification based detection technologies. Having completed two pilot study rounds P44 and P44(1), it was agreed to organise two studies in parallel: a key comparison, CCQM-K61, and a pilot study, CCQM-P44(2) based on the plasmid material generated for the pilot study rounds.
Rationale of this comparison
This key comparison is the first to be carried out by the BAWG. The main aim was to underpin Calibration and Measurement Capabilities (CMCs) for determination of the quantity of plasmid DNA in an aqueous solution. Proficiency testing schemes for the quantitative determination of genetically modified organisms such as the Food analysis Performance Assessment Scheme have highlighted problems with the measurement of DNA quantities using amplification techniques such as real-time quantitative Polymerase Chain Reaction (PCR), particularly by field laboratories, leading to inconsistent data between such laboratories. The first round of the pilot study in this area highlighted the difficulty in achieving comparable results between laboratories. The second round of analysis, using a lower concentration of DNA in the unknown samples, demonstrated good agreement between laboratories and led to the proposal that K61 be carried out on the plasmid material. Key objectives of the study were to establish international comparability in the quantitation of a linearised plasmid DNA, based on a matched standard in a matrix of non-target DNA. This study demonstrates the competence of National Measurement Institutions in this continually evolving area of testing and diagnostics methodology.
Measurement Claim
The measurement claim for CCQM-K61 is:
Quantitation of a linearised plasmid DNA, based on a matched standard in a matrix of non target DNA.
The study supports the participants' competence to perform measurements of DNA using quantitative PCR where a closely matched reference material ("calibrant") with a known value is available and the measurement is carried out in a matrix that does not require extraction of the target DNA or significant pre-treatment.
Participation in CCQM-K61
The National Measurement Institutes that participated in CCQM-K61 are listed in Table 1 . In addition, there were two participants in a parallel pilot study, P44(2). A protocol (Appendix B) was sent to all participants prior to sample distribution and provided information concerning storage and analysis of the sample. Participants were free to use a method of their choice for determination of DNA content. They were asked to report results on the two unknown samples as received.
LGC and NIST coordinated the study.
Test material preparation
The calibrant and unknowns consist of purified target plasmid DNA in a background of non-target plasmid DNA. The plasmid used in this study was the same as that used for Pilot Study P44 and P44.1. It was the responsibility of NIST to prepare the materials for the study and ship them to the participating institutions. The test materials and calibrant were prepared by gravimetric dilution of a stock material containing plasmid DNA. Details of test material preparation and value assignment are given in Appendix A. The materials were checked for homogeneity and stability (including accelerated ageing) during the time that the participants conducted their analysis.
The calibrant assigned value and uncertainty as notified to the participants were 496±15 fg µl -1 .
Methods and instrumentation used
Participants were free to use a method of their choice for the quantitative determination of target DNA content. No recommendations were made as to methodology. All participants carried out their measurements by quantitative PCR. Table 2 gives an overview of the methods applied and the instrumentation used by each CCQM-K61 participant. 
CCQM-K61 participants' results
The CCQM-K61 participants' results, as reported to the coordinators, are given in Table 3 and Table  4 , together with reported uncertainties. The results are shown graphically in figures 1 and 2.
Chi-squared tests of the results provided strong evidence (p-values<0.001) that the participant reported uncertainties were significantly smaller than would be required to explain the observed dispersion, indicating some underestimation of uncertainty for the results on both materials. Tables, participant uncertainties included the calibration material uncertainty as provided prior to review of the data. Subsequent review and discussion identified possible inhomogeneity in the calibrant. This is not accounted for in the reported uncertainties in the Tables,  which are shown exactly as reported by participants, but the additional uncertainty is taken into account in calculation of degrees of equivalence (Section 9). Notes to Table 3 and Table 4 : 1 Expanded uncertainty and coverage factor k reported: Standard uncertainty calculated from
Except as noted in the
Reported uncertainty excluded calibration material uncertainty 3
Reported with expanded uncertainty interval only due to use of log-transform. Supplementary information showed a coverage factor of 2 applied to the standard uncertainty of the logtransformed value. 4
Reported with standard uncertainty only; coverage factor notified separately. 5 DMSC subsequently notified a calculation error in the estimated uncertainty for Unknown 2. The corrected expanded uncertainty was notified as 0.00014 pg/microlitre (0.14 fg µl -1 ) with a corresponding standard uncertainty of 0.07 fg µl -1 and relative uncertainty of 4.4%. Original reported values are, however, used in this report following current guidelines for CIPM key comparisons (CIPM, 2003) . 
Key comparison reference value
The KCRV was based on the traceable measurement of phosphorus in the stock material using ICP-OES, as described in Appendix A. The phosphorus value was corrected for the mass concentration of genomic material, as determined with an E. coli assay described in Appendix A. The uncertainty in the assigned values takes account of the volumetric operations and the uncertainties associated with the correction for genomic material and uses the principles of the relevant ISO and Eurachem guides (ISO 1995; Eurachem 2000) . Values and uncertainties are summarised in Table 5 .
The mean and median of the participant reported results were consistent with the KCRV, giving no reason to reject the traceable assigned value. The KCRV uncertainties in Table 5 do not include any allowance for inhomogeneity, as the participants were supplied with multiple units and inhomogeneity would be expected to contribute to the observed dispersion in the laboratory. The impact of possible inhomogeneity in the calibration materials is discussed below.
9 Equivalence statements
Degrees of equivalence with respect to KCRV
The equivalence statements are calculated following BIPM guidelines, which specify that the degree of equivalence between a NMI result x i and the KCRV x R is expressed as the difference D i calculated as:
together with the uncertainty associated with the difference expressed in the form of an expanded uncertainty.
In CCQM-K61, the KCRV is based on the value of a stock material which was additionally diluted and made available as the calibrant used by all laboratories. The participant uncertainties included the calibration material uncertainty, as does each KCRV uncertainty, making it necessary to allow for correlation in calculating the uncertainty for the degrees of equivalence. In addition, post-hoc analysis of the data indicated a need to allow for possible inhomogeneity in the calibration material, which is catered for via an additional allowance in the uncertainty for the degrees of equivalence.
The corresponding expanded uncertainty
where u hom is the calculated contribution of calibration material inhomogeneity to the uncertainty in
In equation 3, x C is the reference value for the calibration material and u C the associated uncertainty excluding any allowance for inhomogeneity. For CCQM-K61, the participant results x i and KCRV x R are both simple multiples of the calibrant value x C ; equation 3 therefore reduces to
Note that equation 4 includes only one instance of uncertainty due to calibration material inhomogeneity. Inhomogeneity in test materials is expected to contribute to the observed dispersion of results within each laboratory and is therefore expected to be taken account of by proper treatment of the terms associated with observed dispersion in the participants' uncertainty budgets.
The homogeneity term u hom was estimated as 0.04 (expressed as relative standard deviation) from the homogeneity data (Appendix A). This corresponds to the 'between-bottle' uncertainty term u bb in ISO Guide 35 (ISO 2006) , although the precise implementation differs because a) the original analysis was necessarily performed in log space (that is, Ct data) and b) the estimated between-unit variance is negligible, so the allowance is, as suggested by Guide 35, based on the within-group precision. Note also that laboratories may have used calibration materials differently, and in particular that some may have used a different calibrant unit in each run and subsequently averaged the results. This estimate therefore represents a conservative estimate of the effect of inhomogeneity.
Two participating laboratories represent exceptions to equation 4. One participant (KRISS) reported that they had omitted the calibrant uncertainty from their estimated uncertainties; for this laboratory, the correlation term reduces to
(which effectively removes the calibration value uncertainty contribution from u R ). In the case of NMIA, uncertainties were calculated for log 10 (x i ) and the reported interval calculated from the (symmetric) interval about log 10 (x i ). For equivalence statements involving the NMIA results, the participant standard uncertainty u i was calculated from u(log 10 (x i )) using
where u(log 10 (x i )) denotes the standard uncertainty in log 10 (x i ). This standard uncertainty was then combined with other standard uncertainties and the correlation term as in equation 4 to obtain a standard uncertainty u i,R . Since the KCRV uncertainty was comparatively small and the distribution likely to follow an approximately lognormal distribution as used by NMIA, u i,R was transformed to a standard uncertainty in log 10 (x i ), expanded (using k=2) and re-transformed to DNA concentration to give the asymmetric interval reported in Table 6 .
Degrees of equivalence calculated as above are shown in Table 6 , and illustrated graphically in Figure 3 and 
Degrees of equivalence between laboratories
Degrees of equivalence between two laboratories i and j follow identical principles to those quoted with respect to the KCRV, except that a) the pairwise degree of equivalence is given by x i -x j and u R and x R in equation 4 are replaced by u j and x j respectively and b) the homogeneity term appears once for each laboratory, giving (for identical homogeneity contributions)
Adjustments apply as above for uncertainties which did not include calibrant uncertainty and for lognormal distributions. In the case of lognormal distributions for either laboratory, however, expanded uncertainties for pairwise degrees of equivalence are calculated directly from the standard uncertainties in concentration and the resulting mixed distribution was assumed approximately normal, giving symmetric uncertainty intervals in all cases. Pairwise degrees of equivalence are shown in Appendix C. Note 2: Expanded uncertainties used a coverage factor of 2 unless otherwise stated.
Note 3: The expanded uncertainty interval is based on a calculated standard uncertainty associated with a lognormal distribution with mean log equal to log 10 (x i ) as described in the text. 
Degrees of Equivalence
The graph shows the degrees of equivalence between participant results and KCRV. Error bars show uncertainties at k=2 or (for NMIA) the same level of confidence assuming a lognormal distribution. 
The graph shows the degrees of equivalence between participant results and KCRV. Error bars show uncertainties at k=2 or (for NMIA) the same level of confidence assuming a lognormal distribution.
Discussion
Inspection of the participant results (Table 3 and Table 4 ) or degrees of equivalence shows that the uncertainties do not fully account for the observed dispersion of the results. Chi-squared tests of the results confirmed that the dispersion is greater than can be accounted for by the reported uncertainties (p-values were below 0.001 for both materials). The pairwise degrees of equivalence in Appendix C, which are corrected for possible inhomogeneity, further confirm that the discrepancies are not accounted for by inhomogeneity.
In discussion, participants reported that instrument threshold settings might lead to variation in estimated C t values and may affect quantitation. Preliminary study at the coordinating laboratory and several participant laboratories confirms that an effect may exist, but further and much broader study will be required to determine its significance and impact on measurement results. It is recommended that this form a topic for further study within the working group.
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Test material preparation
The calibrant and unknowns consist of purified target plasmid DNA in a background of non-target plasmid DNA. The plasmid used in this study was the same as that used for Pilot Study P44 and P44.1. It was the responsibility of NIST to prepare the materials for the study and ship them to the participating institutions. In addition, the materials were checked for homogeneity and stability (including accelerated ageing) during the time that the participants are conducting their analysis.
Sources of required plasmid
The target plasmid had been previously used in pilot studies. It consisted of a commercial plasmid called pPCR Script Amp SK(+) (from Stratagene). 1 A DNA sequence was synthesized and inserted into the multiple cloning site of the plasmid. This sequence was the target for the quantitation assay. Participants in the current KC and previous pilot studies were provided with the sequence of the inserted DNA as well as suggested primer and probe sequences. For this study, NIST contracted with MTR Scientific to provide NIST with sufficient quantity of the target plasmid for the preparation and analysis of the materials. Because the PCR assays are so sensitive, they are easily prone to contamination. Handling large amounts of the target plasmid in the lab can lead to contamination of assays, and has in the past. Therefore, propagation of the plasmid was done by the contractor. NIST supplied a bacterial culture plate containing cultured colonies of bacteria carrying the plasmid to the contractor. MTR Scientific provided NIST with 7 mg (in 2 mL) of target plasmid. To confirm the correctness of the target sequence, the DNA in the target region was sequenced on both DNA strands by MTR Scientific.
Cleanup and quantitative analysis of the plasmid
The plasmid preparation was cleaned of non-DNA components (RNA, carbohydrates, protein) by sequential treatment with RNAse (200 µg, 37 °C, 45 min), amylase (4 U, 21 °C, 30 min) and then Proteinase K (4 U, 37 °C, 30 min). The plasmid preparation was then extracted with chloroform and washed multiple times with sterile DNAse free water using centrifugal concentrators that retained the DNA but removed small molecules. The concentration of most of the plasmid preparation was diluted to a concentration (~60 µg / mL) suitable for subsequent analysis of DNA phosphorus content. The 260 nm / 280 nm ratio was 1.96. A volume of material was set aside for phosphorus analysis and the remainder was placed in 0.6 mL sterile tubes (Axygen Maximum Recovery) and stored in a -20 °C freezer.
Acid digestion of the plasmid and phosphorus analysis
Quantitation of the DNA in the target plasmid preparation was accomplished by measuring the phosphorus mass fraction in the preparation. Care was taken to digest the organic matrix and use a robust method to minimize the potential for biased assay results. The plasmid material to be used for the phosphorus determinations was digested in a Teflon bottle with approximately 5% concentrated HCl, in high purity water, at elevated temperature. The mixture was prepared gravimetrically with 22.3751 g of plasmid DNA solution + 1.3181 g of concentrated HCl using a Mettler AE200 4-decimal place balance 2 . The preparation was digested at 115 °C for 16 h. After digestion the bottle was weighed again to account for any loss of mass (0.0425 g of 23.6932 g).
The phosphorus determinations were done using the NIST high performance ICP-OES method. A separate study has established that the conditions used in this method are robust with respect to instrument operating conditions. After digestion, the solution introduced to the instrument was a dilute acid solution with the P from the DNA as H 3 PO 4 . A matched calibrant was prepared from NIST SRM 3139a, Phosphorus Standard Solution, Lot # 890607. The result of the analysis with calculated expanded uncertainties was: The P mass was used to calculate the DNA mass fraction of the original preparation accounting for the addition of HCl and loss of mass during heat treatment. The DNA mass fraction was calculated as 58.92 µg DNA / g.
Estimation of the E. coli genomic DNA contamination in the target plasmid preparation
Since the plasmid was propagated in bacteria, some of the total DNA was composed of contaminating E. coli genomic DNA. The genomic DNA in the plasmid preparation was quantitated using a Real-Time PCR reaction for the E. coli 23S gene. The calibrant for this assay was DNA isolated at NIST from a culture of cells. The genomic DNA was cleaned up and quantitated using absorbance at 260 nm. Multiple dilutions were made and several readings were 2 The four decimal place Mettler balance used for these preparations is professionally calibrated once a year. The calibration was recently checked using a set of class M weights and checked in the range of 0.1 to 100 g. At 10 g and 20 g the readings were consistently 10.0001 or 20.0001, at 30 g and higher the mass was 30.0003-4 and at 100 the reading was 100.0006-7. 100 and 200 mg read 0.1000 and 0.2000. These are the readings that would be expected based on the correction factors assigned to the set of weights.
taken of each to reach a consensus value of 115 ng/µL (Table 1) . Gravimetric 1:10 serial dilutions were made of the genomic DNA in order to construct a 5 point standard curve for the PCR assay.
[In separate experiments, this material was compared in a PCR assay with calibration standards prepared for previously isolated E. coli genomic DNA, and the values for the two preparations were found to be very close.] Two PCR runs were conducted on the plasmid preparation on separate days. The calibration of the Rainin pipette used to deliver 5 µL of DNA to each PCR reaction was checked. In each run the five calibrants had three replicates. Six separate gravimetric dilutions were made of the plasmid (1:2, 1:3, 1:4, 1:7, 1:5, and 1:3). Three of the dilutions were analyzed on one day and three on another day. Measurements on five of the six dilutions were replicated 6 times, and the other dilution had 5 replicates. The slopes of the curves were -3.4309 and -3.4445 respectively. The R2 values were 0.997416 and 0.997036 and the intercepts were 30.2 for both. The average value of the replicate measurements for each plasmid dilution was used to calculate the percent of the DNA mass fraction that was not plasmid, but E. coli genomic DNA ( Table 3 ). The average of these values was 6.75%. The value of the plasmid DNA was corrected accordingly.
58.92 µg total DNA/g x 0.0675 = 3.9771 µg E. coli DNA/g 58.92 µg total DNA/g -3.9771 µg E. coli DNA/g = 54.9429 µg plasmid DNA/g
Preparation of the calibrant material and unknowns for K61 from the plasmid stock
The plasmid was linearised by digestion with the restriction endonuclease, Sca1, which cuts the plasmid once at a specific place in the nucleotide sequence on the other side of the plasmid from the amplification target region. A reaction mix was made up of buffer and enzyme and the stock plasmid was diluted gravimetrically into the buffer. After incubation at 37 °C, linearization was checked by electrophoresis of the plasmid DNA through an agarose gel, where linearised DNA migrated slower than intact super coiled plasmid DNA, as expected. The target plasmid required a significant dilution to the agreed upon concentration (0.5 ng plasmid / g) of the solution intended to serve as the stock calibrant. The dilution was approximately 1:26,000 and was done in three serial dilutions corresponding to the cube root of the total dilution (13,363.112 ng plasmid DNA/g / 0.5 ng plasmid DNA/g = 26,726). The cube root of 26,726 is ~29.8. For each dilution, 1.5 g of the plasmid and 43.2 g of diluent DNA were weighed into 50 mL sterile plastic screw capped tubes. Then separate dilutions were made from the third dilution, and these calibrant dilutions constituted the unknowns. The two unknowns were prepared by separate dilutions of the calibrant solution in a similar manner.
The calibrant and two unknown solutions were distributed into sterile 0.6 mL tubes in the PCR product protection hood. The tops of the tubes were sealed in parafilm and all tubes were refrigerated except for the tubes that were going to be used for stability studies at 40 °C and 22 °C.
Calculation of the expanded uncertainty for the calibrant plasmid DNA
Expanded uncertainties for the calibrant (and unknowns) were calculated using the information provided in this report (Appendix A Table 1 ) and were determined to be 3% of the value of the target plasmid DNA or 0.496 ng DNA/g ± 0.0149 ng DNA/g.
Note that all values were converted to mass per unit volume using an assumed conversion factor of 1.0 g mL -1 with uncertainty of 0.01 g mL -1 prior to shipping to participants. The conversion factor uncertainty was included in the uncertainty calculation (see Appendix A 
Stability studies on the prepared materials
Before shipping and during the course of the K61 assay period, the plasmid materials were monitored for stability. Tubes of all three solutions were stored at 40 °C, 22 °C and 5 °C. Tubes were periodically assayed in triplicate using the Q-PCR TaqMan assay for the plasmid on the ABI Prism 7000 Sequence Detection System. Assays were conducted from February 2, 2007 to March 26, 2007 . Fresh tubes were used each time. The threshold crossing (Ct) value was measured. The fluorescent signal from a given reaction will cross the assigned threshold value that is above background fluorescence. The cycle where this occurs is called is the Ct value and it correlates with the concentration of the target DNA in the reaction The higher the concentration of the initial target DNA sequence, the lower the Ct value. Raw data were compiled in Appendix D, Table 1 Analysis of the data showed no evidence of significant instability. There is evidence of a general downward trend in Ct which appeared consistent for all materials and broadly similar across temperatures, suggesting experimental drift rather than temperature-driven deterioration. Note that degradation would typically be manifested in larger Ct values, not smaller values. The data were analysed by linear modelling to assess temperature effects. Appendix A Table 2 shows the linear model coefficients; note the low significance for change in gradient with temperature. ANOVA returned insignificant p-values for the overall effect of temperature in all three materials. Since the observations were treated as independent, the p-values are if anything underestimated; allowing for the random Day effect using mixed effects modelling results in even less significant results for temperature. Thus, although the results confirmed the presence of a significant systematic drift with time, there was no significant temperature effect.
Homogeneity studies
It is important the target plasmid be uniformly dispersed in the diluent DNA. To assess homogeneity, ten tubes were randomly selected from each of the three prepared batches and were assayed using a Q-PCR reaction. In this assay the TaqMan probe was replaced by the DNA intercalating dye, SYBR Green. Each tube was assayed in triplicate and the Ct value recorded. Raw data are shown in Appendix D, Table 2 . All calibrant units were run on a single 96-well plate, distributed sequentially. Unknowns 1 and 2 were run on a single 96-well plate, with replicates placed column-wise on the plate. Plate locations are included in Table D2.2. ANOVA showed a pronounced plate location effect for the Unknowns (Appendix A Table 3a ) but negligible between-unit effects. Variance components (estimated by restricted maximum likelihood estimation) are shown in Appendix A Table 3b ; the between-unit standard deviation in Ct is under 6×10 -7 , corresponding to a between-unit relative standard deviation in concentration of approximately 4×10 -7 . * This is negligible compared to the assigned value uncertainty. The calibrant homogeneity study showed similar variance, giving no evidence of dispersion other than from plate location effects. The calibrant uncertainty provided to participants accordingly made no allowance for inhomogeneity.
However, for reference material certification, ISO Guide 35 (ISO, 2006) recommends that where homogeneity is not detected, an allowance for possible undetected inhomogeneity should be made, based on the residual term in the homogeneity study. In this case, the residual term for the homogeneity study corresponds to a relative standard deviation of approximately 0.07, or 7%; a * This follows from the approximate relationship
, where s(x) indicates the standard deviation associated with a concentration x, RSD(x) indicates the corresponding standard deviation, and C t is the Ct value corresponding to concentration x. The relationship follows from first-order error propagation assuming x∝2
Ct and can be shown to hold well for the small s(C t ) observed here.
similar RSD is observed for the homogeneity data for the calibrant. Allowing for the 3 replicates per unit in the homogeneity study, this approach indicates an allowance for possible undetected inhomogeneity of 0.07/√3=0.04, or 4%, as RSD. This is significant compared to the uncertainties reported by most participants and was therefore taken into account in calculating degrees of equivalence (Section 9 above).
Note: Statistical analysis of stability and homogeneity data used raw Ct values and not calculated concentrations. This is appropriate, and indeed necessary for correct statistical analysis, because a) Ct data show approximately constant variance at different mean Ct, whereas concentrations show very different variance at different concentrations; b) Ct is expected to be approximately normally distributed whereas interpolated concentrations are lognormal (although for small variance in Ct the asymmetry in concentration is negligible at a given concentration level).
Distribution of the K61 materials to participants
The plasmid preparations were in filter-sterilized solutions that include a plasmid-based carrier DNA and buffer. The concentration of the carrier DNA was 5 ng/µL and the buffer was 10 mM Tris-Cl, 0.1 mM EDTA, pH 7.5. Each participant was sent three complete sets of tubes. Each set consisted of:
Diluent DNA in buffer for construction of calibration curves (3 x 1.5 mL vials)
Calibrant DNA with indicated concentration (1 vial)
Two unknown dilutions of calibrant DNA (1 vial each)
Materials were sent by FedEx in foam boxes (inside cardboard boxes) with the materials placed in between two cold gel packs. This packaging was not designed to provide cold temperatures for the duration of shipping but would moderate the temperatures to which the materials were exposed.  3 large tubes of diluent DNA -5 ng/µL of non-target plasmid DNA, tube size = 1.5 mL, volume = > 1.0 mL each  1 small tube of calibrant DNA -0.496 pg/µ L, tube size =0.6 mL, volume = > 0.25 mL  1 small tube of Unknown #1, tube size = 0.6 mL, volume = > 0.25 mL  1 small tube of Unknown #2, tube size = 0.6 mL, volume = > 0.25 mL All plasmid solutions are in a buffer of 10 mM Tris-Cl, 0.1 mM EDTA, pH 7.5. The calibrant and unknown consist of the test plasmid that has been diluted into the diluent DNA, so all tubes contain 5 ng/µL of total plasmid DNA.
The diluent DNA tubes are not labelled. The others have labels on the tubes as well as 1,2 or C marked on the tops. The top of all tubes have been wrapped in parafilm to ensure that they remain closed during transport. The tubes do not have a precise amount of material added to them. If you notice a difference in volume, that is to be expected. The purpose of the diluent DNA is for preparation of the dilutions of the calibrant for the standard curve. It is not necessary to dilute either of the unknowns.
Shipping conditions: We have tried to moderate the temperatures that the materials were exposed to during shipping by placing them in foam boxes with initially frozen gel packs. We have put one or two temperature indicators on the outside of one of the zip-locked plastic envelopes. An unreacted indicator has white rectangles in line with a temperature (both C and F). If the package has reached a particular internal temperature in the scale provided by these monitors, then an irreversible reaction occurs and the indicator turns gray/black. The information is only that the temperature has been reached, not how long the high temperature was maintained. The boxes that travel to warmer climates have two separate indicators in order to increase the temperature range that is monitored. For the duration of the study, we will be periodically monitoring the stability (using Q-PCR) of identical calibrant and unknown plasmid samples stored at three different temperatures. One of the temperatures will be 40 °C.
We will supply additional sets of materials, important in the situation where 1. You notice that material has leaked out of the tubes 2. The package reached high temperature during transport (we will beef up the temperature protection on the replacement package) 3. Your package was held up in government import/customs offices for an extended period of time
The test plasmid has been linearized by digestion with Sca 1 restriction endonuclease which cuts the plasmid once on the opposite side of the plasmid from the target for amplification, leaving the target in the middle of the plasmid. The size of the plasmid is 3165 base pairs. The diluent DNA is a similar sized plasmid. The buffer used to prepare these materials was autoclaved and then the diluent DNA was added and the preparation was filter sterilized. The Calibrant DNA was prepared by adding the test plasmid to the diluent DNA and then the preparation was filter sterilized. The unknowns were prepared as dilutions of the calibrant DNA in diluent DNA. It is recommended that you store the materials at refrigerator temperature for the duration of the study. When you are finished transfer the remaining materials into the freezer for long term storage.
Additional information will be arriving via email. If you have questions or requests concerning the materials please contact Marcia Holden (marcia.holden@nist.gov)
Study Co-ordinators

Appendix C: Pairwise equivalence tables
The following tables show degrees of equivalence and uncertainties between participant laboratories in CCQM-K61. Uncertainties U(D ij ) are given using a coverage factor k=2 throughout.
All values are given in fg DNA per µl of test material (fg µl -1 ).
CCQM-K61: Unknown 1
Lab j Ten tubes of each plasmid concentration were randomly selected and assayed in triplicate using the TaqMan assay for this plasmid. Values are the crossing threshold for each assay. Replicates 1-3 for each tube were placed sequentially along rows on a 96-well plate. 
